Wealthspire Advisors LLC Raises Holdings in Maximus, Inc. (NYSE:MMS)

Wealthspire Advisors LLC increased its position in Maximus, Inc. (NYSE:MMS) by 21.1% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 26,682 shares of the health services provider’s stock after acquiring an additional 4,657 shares during the quarter. Wealthspire Advisors LLC’s holdings in Maximus were worth $1,992,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Hudson Edge Investment Partners Inc. raised its holdings in Maximus by 45.3% during the 4th quarter. Hudson Edge Investment Partners Inc. now owns 10,398 shares of the health services provider’s stock valued at $776,000 after acquiring an additional 3,243 shares during the period. Van Berkom & Associates Inc. grew its position in shares of Maximus by 8.5% in the fourth quarter. Van Berkom & Associates Inc. now owns 1,256,418 shares of the health services provider’s stock valued at $93,792,000 after purchasing an additional 98,264 shares in the last quarter. Handelsbanken Fonder AB raised its stake in shares of Maximus by 14.1% during the 4th quarter. Handelsbanken Fonder AB now owns 15,416 shares of the health services provider’s stock valued at $1,151,000 after purchasing an additional 1,900 shares during the period. Ieq Capital LLC bought a new stake in shares of Maximus during the 4th quarter valued at $541,000. Finally, Bryn Mawr Capital Management LLC lifted its holdings in Maximus by 290.3% during the 4th quarter. Bryn Mawr Capital Management LLC now owns 8,400 shares of the health services provider’s stock worth $627,000 after purchasing an additional 6,248 shares in the last quarter. 97.21% of the stock is currently owned by institutional investors.

Maximus Price Performance

NYSE:MMS opened at $66.12 on Tuesday. Maximus, Inc. has a 52-week low of $64.53 and a 52-week high of $93.97. The stock has a fifty day moving average of $73.68 and a 200 day moving average of $81.48. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. The firm has a market capitalization of $3.74 billion, a price-to-earnings ratio of 14.22 and a beta of 0.72.

Maximus (NYSE:MMS) last issued its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. On average, research analysts expect that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 28th. Stockholders of record on Saturday, February 15th will be issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.81%. The ex-dividend date is Friday, February 14th. Maximus’s dividend payout ratio is currently 25.81%.

Insider Buying and Selling

In related news, insider Michelle F. Link sold 2,208 shares of the firm’s stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $73.83, for a total transaction of $163,016.64. Following the transaction, the insider now directly owns 6,567 shares of the company’s stock, valued at approximately $484,841.61. This trade represents a 25.16 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Ilene R. Baylinson sold 14,500 shares of the stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total transaction of $988,030.00. Following the transaction, the insider now owns 2,512 shares in the company, valued at $171,167.68. The trade was a 85.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders purchased 7,063 shares of company stock worth $502,017. Corporate insiders own 1.60% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on MMS shares. StockNews.com cut Maximus from a “buy” rating to a “hold” rating in a research report on Friday, February 14th. Raymond James raised shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 target price on the stock in a report on Thursday, January 2nd.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.